These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20067809)

  • 1. Highly glycosylated human alpha interferon: An insight into a new therapeutic candidate.
    Ceaglio N; Etcheverrigaray M; Conradt HS; Grammel N; Kratje R; Oggero M
    J Biotechnol; 2010 Mar; 146(1-2):74-83. PubMed ID: 20067809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and biologic characterization of pegylated recombinant IFN-alpha2b.
    Grace M; Youngster S; Gitlin G; Sydor W; Xie L; Westreich L; Jacobs S; Brassard D; Bausch J; Bordens R
    J Interferon Cytokine Res; 2001 Dec; 21(12):1103-15. PubMed ID: 11798469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of carbohydrates on the stability and structure of a hyperglycosylated human interferon alpha mutein.
    Ceaglio N; Etcheverrigaray M; Kratje R; Oggero M
    Biochimie; 2010 Aug; 92(8):971-8. PubMed ID: 20403411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics Versus In Vitro Antiproliferative Potency to Design a Novel Hyperglycosylated hIFN-α2 Biobetter.
    Gugliotta A; Leopold MJ; Mufarrege E; Etcheverrigaray M; Kratje R; Ceaglio N; Oggero M
    Pharm Res; 2021 Jan; 38(1):37-50. PubMed ID: 33443683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel glycosylated human interferon alpha 2b expressed in glycoengineered Pichia pastoris and its biological activity: N-linked glycoengineering approach.
    Katla S; Yoganand KNR; Hingane S; Ranjith Kumar CT; Anand B; Sivaprakasam S
    Enzyme Microb Technol; 2019 Sep; 128():49-58. PubMed ID: 31186110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of in vitro stability and pharmacokinetics of hIFN-α by fusing the carboxyl-terminal peptide of hCG β-subunit.
    Ceaglio N; Gugliotta A; Tardivo MB; Cravero D; Etcheverrigaray M; Kratje R; Oggero M
    J Biotechnol; 2016 Mar; 221():13-24. PubMed ID: 26806490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
    Bell SJ; Fam CM; Chlipala EA; Carlson SJ; Lee JI; Rosendahl MS; Doherty DH; Cox GN
    Bioconjug Chem; 2008 Jan; 19(1):299-305. PubMed ID: 18020402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and biological activity of long-acting recombinant human interferon-α2b.
    Zhang Q; Wang C; Ma F; Yao L; Gao H; Zhu L; Zheng L
    BMC Biotechnol; 2020 Mar; 20(1):16. PubMed ID: 32169063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De-immunized and Functional Therapeutic (DeFT) versions of a long lasting recombinant alpha interferon for antiviral therapy.
    Mufarrege EF; Giorgetti S; Etcheverrigaray M; Terry F; Martin W; De Groot AS
    Clin Immunol; 2017 Mar; 176():31-41. PubMed ID: 28089609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.
    Ramon J; Saez V; Baez R; Aldana R; Hardy E
    Pharm Res; 2005 Aug; 22(8):1374-86. PubMed ID: 16078148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel long-lasting interferon alpha derivatives designed by glycoengineering.
    Ceaglio N; Etcheverrigaray M; Kratje R; Oggero M
    Biochimie; 2008 Mar; 90(3):437-49. PubMed ID: 18039474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ANITVNITV peptide fusion on the bioactivity and pharmacokinetics of human IFN-α2b and a hyper-N-glycosylated variant.
    Gugliotta A; Ceaglio N; Kratje R; Oggero M
    J Biotechnol; 2019 Sep; 303():46-52. PubMed ID: 31336133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pegylation and Cell Based Bioassay of Human Interferon-α2b Along its Docking Studies and Effect on Plasma Half-Life.
    Shahzadi SK; Qadir MA; Mahmood N; Ahmed M
    Protein Pept Lett; 2020; 27(3):219-224. PubMed ID: 31612813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation and antiproliferative activity of hyperglycosylated IFN-α2 potentiate HEK293 cells as biofactories.
    Gugliotta A; Ceaglio N; Raud B; Forno G; Mauro L; Kratje R; Oggero M
    Eur J Pharm Biopharm; 2017 Mar; 112():119-131. PubMed ID: 27867113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method to produce monoPEGylated dimeric cytokines shown with human interferon-α2b.
    Chang CH; Rossi EA; Cardillo TM; Nordstrom DL; McBride WJ; Goldenberg DM
    Bioconjug Chem; 2009 Oct; 20(10):1899-907. PubMed ID: 19736932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-glycan structures and N-glycosylation sites of mouse soluble intercellular adhesion molecule-1 revealed by MALDI-TOF and FTICR mass spectrometry.
    Otto VI; Damoc E; Cueni LN; Schürpf T; Frei R; Ali S; Callewaert N; Moise A; Leary JA; Folkers G; Przybylski M
    Glycobiology; 2006 Nov; 16(11):1033-44. PubMed ID: 16877748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of immunoglobulin G glycosylation in monoclonal and polyclonal species by electrospray and matrix-assisted laser desorption/ionization mass spectrometry.
    Saba JA; Kunkel JP; Jan DC; Ens WE; Standing KG; Butler M; Jamieson JC; Perreault H
    Anal Biochem; 2002 Jun; 305(1):16-31. PubMed ID: 12018942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and Biological Characterization of a Prepared Recombinant Human Interferon Alpha 2b Isoform.
    Shaaban R; El-Sayed WM; Samir S; El-Dabaa E
    Appl Biochem Biotechnol; 2019 May; 188(1):72-86. PubMed ID: 30334171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro biological characterization of IFN-β-1a major glycoforms.
    Mastrangeli R; Rossi M; Mascia M; Palinsky W; Datola A; Terlizzese M; Bierau H
    Glycobiology; 2015 Jan; 25(1):21-9. PubMed ID: 25117008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation.
    Rosendahl MS; Doherty DH; Smith DJ; Carlson SJ; Chlipala EA; Cox GN
    Bioconjug Chem; 2005; 16(1):200-7. PubMed ID: 15656592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.